SCHEMBL7700716

SCHEMBL7700716

CC(C)(C)OC(=O)NCCNC(=O)c1cccc2c1OCCC(C(=O)NC(=N)N)=C2

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.35
NQO2 P16083 1/20 0.35
KCNA5 P22460 1/20 0.35
MALT1 Q9UDY8 1/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
LMNA P02545 2/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
CSNK1D P48730 1/20 0.33
POLB P06746 1/20 0.32
TP53 P04637 1/20 0.32
IDO1 P14902 1/20 0.32
PARP1 P09874 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HTT P42858 2/20 0.32
GLS O94925 1/20 0.31
NAMPT P43490 1/20 0.31
BCHE P06276 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7695015 0.86 KCNA5 (0.37) CXCR2NQO2KCNA5MALT1MAPT
SCHEMBL7700721 0.86 CXCR2 (0.35) CXCR2NQO2KCNA5MALT1MAPT
Hydrochloric Acid SCHEMBL7702260 0.84 PARP1 (0.36) NQO2LMNATP53PARP1HTT
Hydrochloric Acid SCHEMBL7696592 0.83 RAD52 (0.39) PARP1KDM4EHTT
SCHEMBL7702982 0.82 PARP1 (0.43) MAPTPOLBTP53PARP1HTT
Hydrochloric Acid SCHEMBL7697554 0.81 PARP1 (0.42) MAPTPOLBTP53PARP1HTT
SCHEMBL7872528 0.81 NQO2 (0.37) CXCR2NQO2KCNA5MALT1MAPT
SCHEMBL7701178 0.78 PARP1 (0.41) MAPTPOLBTP53PARP1HTT
SCHEMBL7697131 0.77 PARP1 (0.46) MAPTHPGDPOLBTP53PARP1
SCHEMBL7700738 0.76 PARP1 (0.37) MAPTPOLBTP53PARP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed